<DOC>
	<DOCNO>NCT00359151</DOCNO>
	<brief_summary>This study investigate benefit administer celecoxib ( Celebrex ) , selective cyclooxygenase -2 ( COX-2 ) inhibitor , treat osteoarthritis ( OA ) subject undergoing elective unilateral primary total knee arthroplasty ( TKA ) pre-operative phase management post total knee replacement pain , 6 week physical therapy rehabilitation .</brief_summary>
	<brief_title>Celebrex Total Knee Arthroplasty Study</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>The subject male female 18 year old osteoarthritis knee schedule undergo elective unilateral primary total knee arthroplasty OA , perform standardized regimen anesthesia procedure . Subject history inflammatory arthritis ( e.g . rheumatoid arthritis , ankylose spondylitis ) osteoarthritis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Perioperative care total arthroplasty assess opioid consumption</keyword>
</DOC>